Laverock Therapeutics raised €23.3m in seed funding led by Calculus Capital, joined by Eli Lilly, Mercia Ventures, Eos Advisory, Maven Capital and Norcliffe.
01 June 2025
01 June 2025
Total investments received (USD): 43.99M
Round value (USD): 26.84M
Company: Laverock Therapeutics
Related deals
T-Therapeutics in a $32 million series A extension with Tencent, BGF, Sofinnova, F-Prime, Digitalis Ventures, Cambridge Innovation, Sanofi.
Investments
03 November 2025
PhysicsX raised a $20m series B extension with Nvidia
Investments
07 October 2025
Jack & Jill raised $20 million led by Creandum, joined by Dig Ventures, Entrepreneur First, Ada Ventures, Firedrop, Repeat.vc, Episode1, and Playfair,
Investments
03 October 2025
Paid in a $21.6 million seed round led by Lightspeed, joined by FUSE and existing investor EQT Ventures
Investments
18 September 2025
Mimica raised a $26.2 million Series B round led by Paladin Capital Group, with Khosla Ventures, LGVP, and Entrepreneurs First
Investments
14 September 2025
Belgium
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain